Posters

GENITOURINARY CANCER—KIDNEY AND BLADDER

IMvigor010: Primary analysis from a phase III randomized study of adjuvant atezolizumab (atezo) versus observation (obs) in high-risk muscle-invasive urothelial carcinoma (MIUC).Read more...

 90
GENITOURINARY CANCER—KIDNEY AND BLADDER

Tags:

Previous Article

HEAD AND NECK CANCER

Next Article

GENITOURINARY CANCER—PROSTATE, TESTICULAR, AND PENILE

Related Posts

HEALTH SERVICES RESEARCH AND QUALITY IMPROVEMENT

HEALTH SERVICES RESEARCH AND QUALITY IMPROVEMENT

 88

GYNECOLOGIC CANCER

GYNECOLOGIC CANCER

 275

GASTROINTESTINAL CANCER—COLORECTAL AND ANAL

GASTROINTESTINAL CANCER—COLORECTAL AND ANAL

 270